Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy
Atsutaka Minagawa(Kyoto University), Shin Kaneko(Kyoto University Hospital), Yutaka Yasui(St. Jude Children's Research Hospital), Hiroyuki Miyoshi(Washington University in St. Louis), Mahito Nakanishi(Tokiwa University), Kei Kawana(Nihon University), Maiko Takiguchi(Takeda (Japan)), Toshiaki Yoshikawa(Aichi Cancer Center), Shoichi Iriguchi(Kaneka (United States)), Tetsuya Nakatsura(Unknown), Mihoko Kunitomo(Takeda (Japan)), Yohei Kawai(Nagoya University), Rong Zhang(Shenyang Pharmaceutical University), Tomoyuki Fujii(Tohoku University), Akira Hayashi(Kindai University), Masaki Yasukawa(Ehime Prefectural University of Health Science), Akira Watanabe, Yoshiaki Kassai(Takeda (Japan)), Eri Imai(Kyoto University), Yasushi Uemura(Aichi Cancer Center), Akitsu Hotta(Kyoto University)
Cited by 163
Related Papers
Characterization of oligonucleotide transport into living cells.
|Proceedings of the National Academy of Sciences|1989|740
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
|The Lancet Neurology|2017|630
Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays
|Gut|2014|554